Last C$6.83 CAD
Change Today +0.34 / 5.24%
Volume 7.4K
As of 3:59 PM 04/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Geoffrey F. Cox Ph.D.

Non-Executive Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee, Biota Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 150 board members in 7 different organizations across 7 different industries.

See Board Relationships
69$69,157

Background*

Dr. Geoffrey F. Cox, PhD is a Partner of Red Sky Partners LLC. Dr. Cox serves as an Independent Consultant to the Biotechnology and Life Sciences Industry and Principal of Beacon Street Advisors. Dr. Cox served as Chairman, Chief Executive Officer and President of rEVO Biologics (formerly, GTC Biotherapeutics Inc.) from July 2001 to June 15, 2010. Dr. Cox served as the Chairman of Aronex Pharmaceuticals Inc. from 1997 to June 2001 and its Chief Executive Officer since ...

Read Full Background

Corporate Headquarters*

887 Great Northern Way
Vancouver, British Columbia V5T 4T5

Canada

Phone: 604-707-7000
Fax: 604-707-7001

Board Members Memberships*

Chairman of the Board
Director
Non-Executive Director
Independent Director
1994-N/A
Former Chairman and Chief Executive Officer
2000-N/A
Non-Executive Chairman
2000-Present
Non-Executive Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
2001-2010
Former Chairman, Chief Executive Officer and President
2012-Present
Independent Director, Chairman of Compensation Committee and Member of Corporate Governance & Nominating Committee
2014-Present
Director

Education*

BS
University of Birmingham
PhD
University of East Anglia

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$32,523
Total Calculated Compensation$69,157
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
QLT:CN C$6.83 CAD +0.34

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Severin Schwan Ph.D.Chief Executive Officer and Director
Roche Holding AG
SFr.5.1M
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact QLT INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.